- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07714252
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD (VITALVET:ADAPT)
Addressing Symptoms With Person-Centered Treatment (ADAPT) (QUE 25-018)
Panoramica dello studio
Stato
Descrizione dettagliata
Heart failure (HF) and chronic obstructive pulmonary disease (COPD) together affect nearly 1 in 4 Veterans and are among the leading causes of hospitalization, mortality, and poor quality of life in the Veterans Health Administration (VHA). Veterans with these conditions frequently experience depression (50-60%), anxiety (30-40%), breathlessness (44-85%), and fatigue (66-85%). Despite this burden, palliative symptom management and psychosocial support are not routinely delivered in primary care settings.
This study implements a virtual nurse and social worker palliative care team that provides direct patient care to Veterans with HF or COPD at high risk of hospitalization or death. The intervention was tested in a VHA-funded, patient-level randomized controlled trial across two VHA health systems, demonstrating clinically meaningful improvements in quality of life (primary outcome), depression, anxiety, and disease-specific health status at 4 and 6 months, with sustained quality of life effects at 12 months. Documentation of Veteran values and goals increased from 37% to nearly 80% in the intervention group vs. 42% in control.
The current study implements this evidence-based practice (EBP) in routine VHA care across 8 VA health care systems. A nurse and social worker( provide virtual care by phone or VA Video Connect directly to eligible Veterans, collaborating with each Veteran's primary care provider and palliative care clinician. The nurse conducts structured symptom assessments and uses motivational interviewing to help Veterans achieve activity, symptom reduction, and quality of life goals. The social worker delivers brief structured counseling based on behavioral activation and interpersonal psychotherapy, addressing activity goals, pacing, role change, and relaxation. Collaborative case review occurs weekly with a representative primary care provider and palliative care clinician, with placement of orders for the treating PCP to sign. Up to 30 Veterans per practice group per wave are reviewed for eligibility and up to 10 are expected to enroll per practice group per wave.
Practice groups within each site are randomized to one of six implementation waves in a cluster-randomized stepped-wedge design, with one practice group per site rolling out every 3 months beginning July, 2026, such that all 8 sites progress through the same 6-wave timeline in parallel. Covariate-constrained randomization was used to balance site-level characteristics (rurality and site engagement level) across the two implementation support conditions.
In addition to examining the effectiveness of the clinical intervention, this study compares two levels of implementation support. Four sites receive standard implementation support and four sites receive enhanced implementation support. Standard support includes site identification, clinician engagement, tailored training and implementation plans, fidelity monitoring, clinical office hours, adaptations tracking, sustainability planning, and dissemination of data and best practices. Enhanced support includes all standard components plus baseline process mapping, a brainwriting premortem exercise during pre-implementation, and during implementation: structured audit and feedback, updated process maps, and facilitation check-in meetings. During sustainability, enhanced sites additionally receive check-in meetings and emails. Both clinical effectiveness outcomes (Veteran-reported quality of life and related measures) and implementation outcomes (reach, adoption, fidelity, and sustainment) are examined across the two implementation support conditions.
A difference-in-differences analytic approach, aligned with the Callaway and Sant'Anna framework, is used to estimate causal effects of the intervention. Surveys of Veteran-reported outcomes are administered every 6 months to eligible Veterans at all practice groups throughout pre-implementation, implementation, and sustainment periods.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: David Bekelman, MD MPH
- Numero di telefono: (720) 857-2809
- Email: david.bekelman@va.gov
Backup dei contatti dello studio
- Nome: Chelsea A Leonard, PhD
- Email: Chelsea.Leonard@va.gov
Luoghi di studio
-
-
Arizona
-
Phoenix, Arizona, Stati Uniti, 85012
- Phoenix VA Health Care System, Phoenix, AZ
-
Contatto:
- Krystle Johnson-Reed, RN
- Email: krystle.johnson-reed@va.gov
-
Contatto:
- Donna Seton, PA-C
- Email: donna.seton@va.gov
-
-
California
-
Long Beach, California, Stati Uniti, 90822
- VA Long Beach Healthcare System, Long Beach, CA
-
Contatto:
- Donna Sheehan, RN
- Email: donna.sheehan@va.gov
-
Contatto:
- Rebecca Yamarik, MD
- Email: rebecca.yamarik@va.gov
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80045-7211
- Rocky Mountain Regional VA Medical Center, Aurora, CO
-
Contatto:
- Pamela Rice, PhD
- Numero di telefono: 720-218-4015
- Email: Pamela.Rice@va.gov
-
Contatto:
- James P Hill
- Numero di telefono: (720) 830-7685
- Email: James.Hill5@va.gov
-
Investigatore principale:
- David Bekelman, MD MPH
-
-
Louisiana
-
Shreveport, Louisiana, Stati Uniti, 71101-4243
- Overton Brooks VA Medical Center, Shreveport, LA
-
Contatto:
- Stephanie Branch, RN
- Email: stephanie.branch@va.gov
-
Contatto:
- Marilyn Latin, MD
- Email: Marilyn.Latin@va.gov
-
-
Pennsylvania
-
Lebanon, Pennsylvania, Stati Uniti, 17042-7529
- Lebanon VA Medical Center, Lebanon, PA
-
Contatto:
- Melissa Buchinski, RN
- Email: melissa.buchinski@va.gov
-
Contatto:
- Rachel Causak, MD
- Email: Rachel.Causak@va.gov
-
-
Rhode Island
-
Providence, Rhode Island, Stati Uniti, 02908-4734
- Providence VA Medical Center, Providence, RI
-
Contatto:
- Patrician Lamarre, RN
- Email: patricia.lamarre@va.gov
-
Contatto:
- Mitchell Wice, MD
- Email: mitchell.wice2@va.gov
-
-
Wyoming
-
Cheyenne, Wyoming, Stati Uniti, 82001
- Cheyenne VA Medical, Cheyenne, WY
-
Contatto:
- Erin Kramer, RN
- Email: erin.kramer@va.gov
-
Contatto:
- Jannene Sebesta, MD
- Email: jannene.sebesta@va.gov
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- At least one primary care encounter in the past year, identified by primary care stop codes (301, 322, 323, 342, 348, 350, 704)
- Diagnosed with heart failure, COPD, or interstitial lung disease, defined as 2 or more outpatient or community care provider visit encounters with a qualifying ICD code at least 30 days apart, or 1 inpatient hospitalization with a qualifying ICD code as the primary discharge diagnosis, within the past year
- Care Assessment Need (CAN) 3.0 score ≥ 90 at some point in the prior 6 months
- Poor self-reported quality of life, defined as a FACT-G score ≤ 70 at screening
- Consistent access to a telephone
Exclusion Criteria:
- Dementia diagnosis (any inpatient, outpatient, or community care encounter with qualifying ICD code in the prior 3 years)
- Cancer diagnosis (2 or more outpatient or community care provider visit encounters, or 1inpatient primary discharge diagnosis, with a qualifying ICD code in the prior 1 year)
- Current substance misuse (at least 1 inpatient or outpatient encounter with a qualifying substance/alcohol ICD code or stop code in the prior 6 months)
- Currently receiving palliative care (at least 1 inpatient or outpatient encounter with palliative care stop codes 351 or 353 in the prior 1 year)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Ricerca sui servizi sanitari
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione sequenziale
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: EBP + Enhanced Implementation Support
Four VA sites (and their associated practice groups) receive the virtual nurse and social worker palliative care intervention supported by enhanced implementation support.
Enhanced support includes all standard components plus additional pre-implementation activities (baseline process mapping and a structured brainwriting premortem exercise), additional implementation activities (structured audit and feedback, iteratively updated process maps, and facilitation check-in meetings), and additional sustainability activities (check-in meetings and emails).
Practice groups within these sites roll out in a stepped-wedge design with one practice group per wave across 6 waves.
|
A virtual nurse and social worker team provides direct care to eligible Veterans with heart failure or COPD by phone or VA Video Connect.
The nurse conducts structured symptom assessments and uses motivational interviewing to address the Veteran's most bothersome symptom (breathlessness, fatigue, depression, anxiety, or sleep disturbance).The social worker delivers brief structured counseling based on behavioral activation and interpersonal psychotherapy, including modules on activity goals, pacing, role change, and relaxation.
The team engages in weekly collaborative case review with a representative primary care provider and palliative care physician and places orders for the treating PCP to consider.
Nurses and social workers receive 8 hours of training in primary palliative care competencies.
Altri nomi:
Enhanced implementation support includes all standard support components plus: during pre-implementation, creation of baseline process maps and a structured brainwriting premortem exercise to identify implementation barriers; during implementation, structured audit and feedback, iteratively updated process maps, and facilitation check-in meetings; during sustainability, ongoing check-in meetings and emails.
Delivered to across all phases (pre-implementation, implementation, and sustainability).
Altri nomi:
|
|
Sperimentale: EBP + Standard Implementation Support
Four VA sites (and their associated practice groups) receive the virtual nurse and social worker palliative care intervention supported by standard implementation support.
Standard support includes clinician engagement, clinician education and suggested implementation plans, fidelity monitoring, clinical office hours, adaptations tracking, sustainability planning, and dissemination of data and best practices.
Practice groups within these sites roll out in a stepped-wedge design with one practice group per wave across 6 waves.
|
A virtual nurse and social worker team provides direct care to eligible Veterans with heart failure or COPD by phone or VA Video Connect.
The nurse conducts structured symptom assessments and uses motivational interviewing to address the Veteran's most bothersome symptom (breathlessness, fatigue, depression, anxiety, or sleep disturbance).The social worker delivers brief structured counseling based on behavioral activation and interpersonal psychotherapy, including modules on activity goals, pacing, role change, and relaxation.
The team engages in weekly collaborative case review with a representative primary care provider and palliative care physician and places orders for the treating PCP to consider.
Nurses and social workers receive 8 hours of training in primary palliative care competencies.
Altri nomi:
Standard implementation support includes clinician engagement, clinician education and suggested implementation plans, fidelity monitoring, clinical office hours, adaptations tracking, sustainability planning, and dissemination of data and best practices.
Delivered to across all phases (pre-implementation, implementation, and sustainability).
Altri nomi:
|
|
Nessun intervento: Usual Care (Pre-Implementation Control Period)
Practice groups during their pre-implementation period provide usual care for eligible Veterans with heart failure or COPD without the virtual nurse and social worker team.
In the stepped-wedge design, all practice groups eventually transition to their assigned intervention arm.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Health-Related Quality of Life - Functional Assessment of Chronic Illness Therapy-General (FACT-G) Total Score
Lasso di tempo: Assessed every 6 months from pre-implementation through sustainment (up to approximately 30 months); primary effectiveness comparison at the end of each Veteran's intervention period (approximately 4-6 months after enrollment)
|
The FACT-G is a 27-item Veteran-reported measure of health-related quality of life across four domains: physical, social/family, emotional, and functional well-being.
Total scores range from 0 to 108, with higher scores indicating better quality of life.
A 4-point difference represents the minimal clinically important difference in this population.
|
Assessed every 6 months from pre-implementation through sustainment (up to approximately 30 months); primary effectiveness comparison at the end of each Veteran's intervention period (approximately 4-6 months after enrollment)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Depression - Patient Health Questionnaire-8 (PHQ-8)
Lasso di tempo: Every 6 months from Start of pre-implementation through end of sustainment phase, an average of 2.5 years
|
Veteran-reported 8-item depression symptom scale.
Scores range from 0 to 24; higher scores indicate greater depression severity.
Clinically meaningful thresholds occur at increments of 4 points.
|
Every 6 months from Start of pre-implementation through end of sustainment phase, an average of 2.5 years
|
|
Anxiety - Generalized Anxiety Disorder-7 (GAD-7)
Lasso di tempo: Every 6 months from Start of pre-implementation through end of sustainment phase, an average of 2.5 years
|
Veteran-reported 7-item anxiety symptom scale.
Scores range from 0 to 21; higher scores indicate greater anxiety severity.
|
Every 6 months from Start of pre-implementation through end of sustainment phase, an average of 2.5 years
|
|
Suicidality - Columbia Suicide Severity Rating Scale (C-SSRS)
Lasso di tempo: Every 6 months from Start of pre-implementation through end of sustainment phase, an average of 2.5 years
|
Veteran-reported assessment of suicidal ideation and behavior severity.
|
Every 6 months from Start of pre-implementation through end of sustainment phase, an average of 2.5 years
|
|
Documentation of Goals and Preferences/Life-Sustaining Treatment Note
Lasso di tempo: Baseline (any prior documentation) and at 6 and 12 months after Veteran enrollment (any new or updated documentation during follow-up)
|
Binary indicator of goals and preferences/life-sustaining treatment note (not titles serve the same purpose but can have either name) is present in the VA electronic health record at baseline, and whether any new or updated documentation occurs during the follow-up period.
Ascertained from VA Corporate Data Warehouse Health Factors and TIU notes.
|
Baseline (any prior documentation) and at 6 and 12 months after Veteran enrollment (any new or updated documentation during follow-up)
|
|
All-Cause Mortality
Lasso di tempo: 1 year after Veteran enrollment
|
Death from any cause, ascertained from the VA Death Ascertainment File.
|
1 year after Veteran enrollment
|
|
All-Cause Hospitalization
Lasso di tempo: 1 year after Veteran enrollment
|
Any unplanned VA or VA-paid community hospitalization, ascertained from the VA Corporate Data Warehouse (inpatient) and Consolidated Data Set (community care).
|
1 year after Veteran enrollment
|
|
Hospice Utilization
Lasso di tempo: 1 year after Veteran enrollment
|
Time to first hospice enrollment, ascertained from VA inpatient records.
|
1 year after Veteran enrollment
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Reach - Proportion of Eligible Veterans Enrolled
Lasso di tempo: Assessed per implementation wave through end of implementation phase(approximately 18 months from Wave 1 start)
|
Number and proportion of eligible Veterans at each practice group who enroll in the intervention, compared across standard and enhanced implementation support sites.
Representativeness by sex, race, ethnicity, and rurality also examined.
|
Assessed per implementation wave through end of implementation phase(approximately 18 months from Wave 1 start)
|
|
Fidelity - Proportion of Intervention Modules Completed
Lasso di tempo: Start through end of implementation phase, an average of 1.5 years
|
Proportion of enrolled Veterans for whom the nurse and social worker complete all required intervention modules, as documented in the VA electronic health record.
Compared across standard and enhanced implementation support sites.
|
Start through end of implementation phase, an average of 1.5 years
|
|
Adoption - Proportion of Practice Groups Implementing the Intervention as Planned
Lasso di tempo: Start through end of implementation phase, an average of 1.5 years
|
Number and proportion of practice groups that adopt and deliver the intervention, compared across standard and enhanced implementation support sites.
|
Start through end of implementation phase, an average of 1.5 years
|
|
Sustainment - Intent to Maintain Program at End of Implementation Phase
Lasso di tempo: End of implementation phase (approximately 18 months after Wave 1 start)
|
Proportion of practice groups and sites reporting intent to sustain the intervention beyond the study period, compared across standard and enhanced implementation support conditions.
Barriers and facilitators to sustainment also assessed qualitatively.
|
End of implementation phase (approximately 18 months after Wave 1 start)
|
|
Effectiveness - Costs of Care
Lasso di tempo: Start through end of implementation phase, an average of 1.5 years
|
In-patient hospitalizations, outpatient care ED, hospice utilization and costs (VA-delivered and VA-purchased)
|
Start through end of implementation phase, an average of 1.5 years
|
|
Cost of implementation
Lasso di tempo: Start through end of implementation phase, an average of 1.5 years
|
costs of replication for new settings, delivery of implementation strategies, delivery of intervention
|
Start through end of implementation phase, an average of 1.5 years
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: David Bekelman, MD MPH, Rocky Mountain Regional VA Medical Center, Aurora, CO
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattia cardiovascolare
- Processi patologici
- Malattie cardiache
- Malattia cronica
- Attributi della malattia
- Malattie delle vie respiratorie
- Malattie polmonari
- Malattie polmonari, ostruttive
- Condizioni patologiche, segni e sintomi
- Arresto cardiaco
- Malattia polmonare, cronica ostruttiva
- Malattie polmonari, interstiziale
Altri numeri di identificazione dello studio
- QUX 26-007
- QUE 25-018 (Altro numero di sovvenzione/finanziamento: VA Quality Enhancement Research Initiative (QUERI))
- QUX 26-006 (VA Quality Enhancement Research Initiative (QUERI))
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Arresto cardiaco
-
Region SkaneIscrizione su invitoInsufficienza cardiaca Classe II della New York Heart Association (NYHA). | Insufficienza cardiaca Classe III della New York Heart Association (NYHA).Svezia
-
Yonsei UniversityReclutamentoIschemic Heart Disease | Cardiopatia Non IschemicaCorea del Sud
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus Copernicus... e altri collaboratoriTerminatoInsufficienza cardiaca, sistolica | Insufficienza cardiaca con frazione di eiezione ridotta | Scompenso cardiaco Classe IV della New York Heart Association | Scompenso cardiaco Classe III della New York Heart AssociationPolonia
-
V-Wave LtdJohnson & JohnsonNon ancora reclutamentoInsufficienza cardiaca congestizia | Insufficienza cardiaca e frazione di eiezione ridotta | Scompenso cardiaco Classe III della New York Heart Association | Heart Failure Chronic
-
University of WashingtonAmerican Heart AssociationCompletatoInsufficienza cardiaca, congestizia | Alterazione mitocondriale | Scompenso cardiaco Classe IV della New York Heart AssociationStati Uniti
-
Portuguese Association of Interventional CardiologyMedtronicReclutamentoStenosi Aortica Sintomatica Grave (Definita come Classe New York Heart Association (NYHA) ≥ II)Portogallo